Compare
Up to four compounds, side by side.
Useful for choosing between similar peptides or planning a stack.
Add a peptide
| Attribute | GLP-1 / Glucagon Dual Efinopegdutide |
|---|---|
| Summary | GLP-1/glucagon agonist studied primarily for fatty liver disease. |
| Mechanism | GLP-1/glucagon agonist studied primarily for fatty liver disease. |
| Top outcomes |
|
| Evidence | emerging |
| Half-life | Long (days+) |
| Administration | subq |
| Legal status | research only |
| Safety | Educational reference only. Long-term human safety varies; consult a peptide-literate clinician. |